Tyzavan is supplied as a single-dose bag in 7 presentations allowing for dosing flexibility. Tyzavan ™ (vancomycin injection), a ready-to-infuse, room temperature stable formulation of vancomycin, is ...
TYZAVAN ™ is a glycopeptide antibacterial indicated for the treatment of the following infections in adult and pediatric patients (1 month and older) for whom appropriate dosing with this formulation ...
Ready-to-use sepsis therapy marks new advancement in time-critical treatment LONDON, Dec. 8, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today ...
Hikma has obtained permission from the Food and Drug Administration for a novel formulation of the first-of-its-kind, ready-to-infuse formulation of vancomycin, under the brand name Tyzavan ...
C. difficile infection recurrence rates were numerically lower with vancomycin than with placebo, though the difference was not significant. However, the results could be clinically meaningful, an ...
LONDON, July 2, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announced the approval of a novel formulation of the first-of-its-kind, ready-to ...
Vancomycin is the drug of choice for treating pulmonary infections caused by methicillinresistant Staphylococcus aureus (MRSA) in people with cystic fibrosis (PwCF). This study characterized the ...
Intraoperative Vancomycin Pharmacokinetics in Cardiac Surgery With or Without Cardiopulmonary Bypass
Two hundred thirty-six consecutive patients undergoing cardiac surgery (primarily CABG or valve replacement) were enrolled in the study: 215 had on-pump and 21 had off-pump cardiac surgical procedures ...
The following is a summary of “Vancomycin Monitoring for Treatment of Acute Pulmonary Exacerbations of Adult Cystic Fibrosis Patients,” published in the May 2025 issue of Pulmonary Medicine by Smith ...
JUPITER, Fla.--(BUSINESS WIRE)--DoseMe, a leader in model-informed precision dosing (MIPD), today announced that Senior Care Partners (PACE) has implemented DoseMeRx to modernize vancomycin dosing in ...
SAN FRANCISCO, Oct. 29, 2024 /PRNewswire/ -- InsightRX – the leader in Bayesian model-informed precision dosing (MIPD) software – today announced it will present two research abstracts at ACoP15 2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback